Cargando…
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
BACKGROUND: Although the SARS-CoV-2 Omicron variant is considered to induce less severe disease, there have been no consistent results on the extent of the decrease in severity. OBJECTIVES: To compare the clinical outcomes of COVID-19–positive patients with Omicron and Delta variant infection. DATA...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023211/ https://www.ncbi.nlm.nih.gov/pubmed/36934872 http://dx.doi.org/10.1016/j.cmi.2023.03.017 |
_version_ | 1784908882460540928 |
---|---|
author | Hu, Fei-Hong Jia, Yi-Jie Zhao, Dan-Yan Fu, Xue-Lei Zhang, Wan-Qing Tang, Wen Hu, Shi-Qi Wu, Hua Ge, Meng-Wei Du, Wei Shen, Wang-Qin Zhu, Bin Chen, Hong-Lin |
author_facet | Hu, Fei-Hong Jia, Yi-Jie Zhao, Dan-Yan Fu, Xue-Lei Zhang, Wan-Qing Tang, Wen Hu, Shi-Qi Wu, Hua Ge, Meng-Wei Du, Wei Shen, Wang-Qin Zhu, Bin Chen, Hong-Lin |
author_sort | Hu, Fei-Hong |
collection | PubMed |
description | BACKGROUND: Although the SARS-CoV-2 Omicron variant is considered to induce less severe disease, there have been no consistent results on the extent of the decrease in severity. OBJECTIVES: To compare the clinical outcomes of COVID-19–positive patients with Omicron and Delta variant infection. DATA SOURCES: Searches were implemented up to 8 November 2022 in PubMed, Web of Science, BioRvix, and MedRvix. STUDY ELIGIBILITY CRITERIA: Eligible studies were cohort studies reporting the clinical outcomes of COVID-19–positive patients with Omicron and Delta variant infection, including hospitalization, intensive care unit (ICU) admission, receiving invasive mechanical ventilation (IMV), and death. PARTICIPANTS: COVID-19–positive patients with Omicron and Delta variant infection. ASSESSMENT OF RISK OF BIAS: Risk of bias was assessed employing the Newcastle-Ottawa Scale. METHODS OF DATA SYNTHESIS: Random-effect models were employed to pool the ORs and 95% CIs to compare the risk of clinical outcome. I(2) was employed to evaluate the heterogeneity between studies. RESULTS: A total of 33 studies with 6 037 144 COVID-19–positive patients were included in this meta-analysis. In the general population of COVID-19–positive patients, compared with Delta, Omicron variant infection resulted in a decreased risk of hospitalization (10.24% vs. 4.14%, OR = 2.91, 95% CI = 2.35–3.60), ICU admission (3.67% vs. 0.48%, OR = 3.64, 95% CI = 2.63–5.04), receiving IMV (3.93% vs. 0.34%, OR = 3.11, 95% CI = 1.76–5.50), and death (2.40% vs. 0.46%, OR = 2.97, 95% CI = 2.17–4.08). In the hospitalized patients with COVID-19, compared with Delta, Omicron variant infection resulted in a decreased risk of ICU admission (20.70% vs. 12.90%, OR = 1.63, 95% CI = 1.32–2.02), receiving IMV (10.90% vs. 5.80%, OR = 1.65, 95% CI = 1.28–2.14), and death (10.72% vs. 7.10%, OR = 1.44, 95% CI = 1.22–1.71). CONCLUSIONS: Compared with Delta, the severity of Omicron variant infection decreased. |
format | Online Article Text |
id | pubmed-10023211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100232112023-03-21 Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients Hu, Fei-Hong Jia, Yi-Jie Zhao, Dan-Yan Fu, Xue-Lei Zhang, Wan-Qing Tang, Wen Hu, Shi-Qi Wu, Hua Ge, Meng-Wei Du, Wei Shen, Wang-Qin Zhu, Bin Chen, Hong-Lin Clin Microbiol Infect Systematic Review BACKGROUND: Although the SARS-CoV-2 Omicron variant is considered to induce less severe disease, there have been no consistent results on the extent of the decrease in severity. OBJECTIVES: To compare the clinical outcomes of COVID-19–positive patients with Omicron and Delta variant infection. DATA SOURCES: Searches were implemented up to 8 November 2022 in PubMed, Web of Science, BioRvix, and MedRvix. STUDY ELIGIBILITY CRITERIA: Eligible studies were cohort studies reporting the clinical outcomes of COVID-19–positive patients with Omicron and Delta variant infection, including hospitalization, intensive care unit (ICU) admission, receiving invasive mechanical ventilation (IMV), and death. PARTICIPANTS: COVID-19–positive patients with Omicron and Delta variant infection. ASSESSMENT OF RISK OF BIAS: Risk of bias was assessed employing the Newcastle-Ottawa Scale. METHODS OF DATA SYNTHESIS: Random-effect models were employed to pool the ORs and 95% CIs to compare the risk of clinical outcome. I(2) was employed to evaluate the heterogeneity between studies. RESULTS: A total of 33 studies with 6 037 144 COVID-19–positive patients were included in this meta-analysis. In the general population of COVID-19–positive patients, compared with Delta, Omicron variant infection resulted in a decreased risk of hospitalization (10.24% vs. 4.14%, OR = 2.91, 95% CI = 2.35–3.60), ICU admission (3.67% vs. 0.48%, OR = 3.64, 95% CI = 2.63–5.04), receiving IMV (3.93% vs. 0.34%, OR = 3.11, 95% CI = 1.76–5.50), and death (2.40% vs. 0.46%, OR = 2.97, 95% CI = 2.17–4.08). In the hospitalized patients with COVID-19, compared with Delta, Omicron variant infection resulted in a decreased risk of ICU admission (20.70% vs. 12.90%, OR = 1.63, 95% CI = 1.32–2.02), receiving IMV (10.90% vs. 5.80%, OR = 1.65, 95% CI = 1.28–2.14), and death (10.72% vs. 7.10%, OR = 1.44, 95% CI = 1.22–1.71). CONCLUSIONS: Compared with Delta, the severity of Omicron variant infection decreased. European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-07 2023-03-18 /pmc/articles/PMC10023211/ /pubmed/36934872 http://dx.doi.org/10.1016/j.cmi.2023.03.017 Text en © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Systematic Review Hu, Fei-Hong Jia, Yi-Jie Zhao, Dan-Yan Fu, Xue-Lei Zhang, Wan-Qing Tang, Wen Hu, Shi-Qi Wu, Hua Ge, Meng-Wei Du, Wei Shen, Wang-Qin Zhu, Bin Chen, Hong-Lin Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
title | Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
title_full | Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
title_fullStr | Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
title_full_unstemmed | Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
title_short | Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
title_sort | clinical outcomes of the severe acute respiratory syndrome coronavirus 2 omicron and delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023211/ https://www.ncbi.nlm.nih.gov/pubmed/36934872 http://dx.doi.org/10.1016/j.cmi.2023.03.017 |
work_keys_str_mv | AT hufeihong clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT jiayijie clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT zhaodanyan clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT fuxuelei clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT zhangwanqing clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT tangwen clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT hushiqi clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT wuhua clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT gemengwei clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT duwei clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT shenwangqin clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT zhubin clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients AT chenhonglin clinicaloutcomesofthesevereacuterespiratorysyndromecoronavirus2omicronanddeltavariantsystematicreviewandmetaanalysisof33studiescovering6037144coronavirusdisease2019positivepatients |